title: [Characterisation of DNA methylation biomarkers for bladder cancer].
abstract: Despite considerable advances in recent years in our understanding of the genetic changes occurring in urinary bladder cancer, similar progress in the field of epigenetics has hitherto been lacking. Increasingly, however, focus has shifted in the direction of aberrant DNA methylation as a result of recent studies showing the direct impact of such promoter hypermethylation on the loss of tumor suppressor gene expression and function, therefore potentially affecting tumor genesis and progression. The purpose of this study is the identification and characterization of new DNA methylation markers in urinary bladder cancer, with the expectation that these markers could then be incorporated in a multi-gene panel for clinical use in early cancer detection. In addition, better understanding of the signalling pathways involved will undoubtedly impact the development of new treatment strategies. Potential candidate genes, including the Wnt antagonist SFRP5 among others, will be validated by different epigenetic techniques using invasive and superficial urothelial cell lines as well as tumor and urine samples from bladder cancer patients.
authors.affiliation: Institut für Pathologie, Arbeitsgruppe Molekulare Onkologie, Universitätsklinikum der RWTH Aachen, Aachen.
authors.forename: P
authors.initials: P
authors.lastname: Antony
authors.forename: M
authors.initials: M
authors.lastname: Rose
authors.forename: N T
authors.initials: NT
authors.lastname: Gaisa
authors.forename: S
authors.initials: S
authors.lastname: Alkaya
authors.forename: A
authors.initials: A
authors.lastname: Heidenreich
authors.forename: R
authors.initials: R
authors.lastname: Knüchel
authors.forename: E
authors.initials: E
authors.lastname: Dahl
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D014408:Biomarkers, Tumor / Q000235:genetics*; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology*; D045744:Cell Line, Tumor; D002872:Chromosome Deletion; D019175:DNA Methylation / Q000235:genetics*; D004252:DNA Mutational Analysis; D042241:Early Diagnosis; D057890:Epigenomics; D005136:Eye Proteins / Q000235:genetics; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics; D009361:Neoplasm Invasiveness / Q000235:genetics / Q000473:pathology; D009367:Neoplasm Staging; D011379:Prognosis; D011401:Promoter Regions, Genetic / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D001743:Urinary Bladder / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology*; D000094742:Secreted Frizzled-Related Proteins
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D014408:Biomarkers, Tumor; D005136:Eye Proteins; D008565:Membrane Proteins; D012333:RNA, Messenger; C118511:SFRP5 protein, human; D000094742:Secreted Frizzled-Related Proteins
references.citation: Nat Rev Genet. 2002 Jun;3(6):415-28
references.pmid: 12042769
references.citation: Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2109-16
references.pmid: 16609023
references.citation: Cancer Res. 2001 Sep 15;61(18):6688-92
references.pmid: 11559536
references.citation: Br J Cancer. 2008 Mar 25;98(6):1147-56
references.pmid: 18283316
references.citation: Int J Cancer. 2003 May 1;104(5):611-6
references.pmid: 12594816
references.citation: N Engl J Med. 2008 Mar 13;358(11):1148-59
references.pmid: 18337604
references.citation: J Natl Cancer Inst. 2006 Jul 19;98(14):996-1004
references.pmid: 16849682
references.citation: Carcinogenesis. 2006 Mar;27(3):361-73
references.pmid: 16352616
references.citation: Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3
references.pmid: 5279523
references.citation: Eur Urol. 2008 May;53(5):909-16
references.pmid: 18162285
references.citation: Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1603-8
references.pmid: 9990071
references.citation: Clin Cancer Res. 2005 Jun 15;11(12):4415-29
references.pmid: 15958626
references.citation: Clin Cancer Res. 2004 Nov 15;10(22):7457-65
references.pmid: 15569975
references.citation: Nat Med. 1997 Jun;3(6):621-4
references.pmid: 9176487
references.citation: Cancer Res. 2001 Apr 15;61(8):3225-9
references.pmid: 11309270
references.citation: Histopathology. 2009 Jun;54(7):885-900
references.pmid: 19178589
references.citation: N Engl J Med. 2003 Nov 20;349(21):2042-54
references.pmid: 14627790
references.citation: Curr Opin Oncol. 2009 May;21(3):272-7
references.pmid: 19370808
references.citation: Clin Cancer Res. 2007 Apr 1;13(7):2046-53
references.pmid: 17404085
references.citation: Clin Cancer Res. 2004 Mar 15;10(6):1887-93
references.pmid: 15041703
references.citation: Nat Rev Genet. 2007 Apr;8(4):286-98
references.pmid: 17339880
references.citation: Int J Cancer. 2001 Oct 15;94(2):153-6
references.pmid: 11668491
references.citation: Carcinogenesis. 2008 May;29(5):991-8
references.pmid: 18356147